Torrent Pharmaceuticals has informed that it enclosed soft copy of the Integrated Annual Report 2022-23 (comprising of Notice calling 50th Annual General Meeting (AGM) along with Audited Financial Statements, Directors' Report, Auditors' Report, etc.) of Torrent Pharmaceuticals (the Company) in compliance with Regulation 34(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations').
The above information is a part of company’s filings submitted to BSE.